THE GLYCOSYLATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TRANSMEMBRANE GLYCOPROTEIN (GP41) IS IMPORTANT FOR THE EFFICIENT INTRACELLULAR-TRANSPORT OF THE ENVELOPE PRECURSOR GP160

被引:44
|
作者
FENOUILLET, E [1 ]
JONES, IM [1 ]
机构
[1] FAC MED NORD, INST FEDARAT RECH JEAN ROCHE, CNRS, F-13916 MARSEILLE, FRANCE
来源
关键词
D O I
10.1099/0022-1317-76-6-1509
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The role of the glycans of the human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) in the intracellular events of Env precursor (gp160) biosynthesis has been examined by the use of a mutant gp160 in which the cluster of conserved glycosylation sites within the gp41 domain (Asn-621, -630 and -642) has been mutated. Expression of the wild-type and mutant forms of gp160 in BHK-21 cells using recombinant vaccinia viruses has shown that the kinetics of the events occurring in the endoplasmic reticulum (ER) were normal: both Env proteins had similar kinetics of disulphide bond formation, as determined by the acquisition of CD4-binding capability, and both had similar kinetics of oligomer formation. However, in contrast to the parental molecule, mutated gp160 displayed relatively slow transport from the cis to the medial Golgi where it was retained in the oligomeric state. Transport to the trans Golgi was impaired, as determined by the sensitivity of gp160 to glycosidases. Cleavage of mutated gp160 at the gp120/gp41 junction was substantially reduced but this was apparently not due to the involvement of the gp41 glycosylation in the cleavage reaction by furin inasmuch as, in the baculovirus system, mutated gp160 could be cleaved when recombinant furin was co-expressed. The reduced cleavage in mammalian cells may thus reflect the impaired routing of mutated Env to the compartment where cleavage occurs. The glycan component of gp41 is, therefore, important for the efficient intracellular transport and processing of gp160. gp160 lacking gp41 carbohydrates is an additional example, among few others, of a protein lacking glycans that is arrested in the Golgi rather than the ER following its biosynthesis.
引用
收藏
页码:1509 / 1514
页数:6
相关论文
共 50 条
  • [41] SPECIFICITY OF ANTIBODIES PRODUCED AGAINST NATIVE OR DESIALYLATED HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RECOMBINANT GP160
    BENJOUAD, A
    GLUCKMAN, JC
    MONTAGNIER, L
    BAHRAOUI, E
    [J]. JOURNAL OF VIROLOGY, 1993, 67 (03) : 1693 - 1697
  • [42] THE CONVERTASES FURIN AND PC1 CAN BOTH CLEAVE THE HUMAN-IMMUNODEFICIENCY-VIRUS (HIV)-1 ENVELOPE GLYCOPROTEIN GP160 INTO GP120 (HIV-I SU) AND GP41 (HIV-I TM)
    DECROLY, E
    VANDENBRANDEN, M
    RUYSSCHAERT, JM
    COGNIAUX, J
    JACOB, GS
    HOWARD, SC
    MARSHALL, G
    KOMPELLI, A
    BASAK, A
    JEAN, F
    LAZURE, C
    BENJANNET, S
    CHRETIEN, M
    DAY, R
    SEIDAH, NG
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (16) : 12240 - 12247
  • [43] HUMAN MONOCLONAL-ANTIBODIES TO THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) TRANSMEMBRANE GLYCOPROTEIN GP41 ENHANCE HIV-1 INFECTION INVITRO
    ROBINSON, WE
    KAWAMURA, T
    GORNY, MK
    LAKE, D
    XU, JY
    MATSUMOTO, Y
    SUGANO, T
    MASUHO, Y
    MITCHELL, WM
    HERSH, E
    ZOLLAPAZNER, S
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (08) : 3185 - 3189
  • [44] A BROADLY NEUTRALIZING HUMAN MONOCLONAL-ANTIBODY AGAINST GP41 OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    PURTSCHER, M
    TRKOLA, A
    GRUBER, G
    BUCHACHER, A
    PREDL, R
    STEINDL, F
    TAUER, C
    BERGER, R
    BARRETT, N
    JUNGBAUER, A
    KATINGER, H
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (12) : 1651 - 1658
  • [45] HUMAN-IMMUNODEFICIENCY-VIRUS TRANSMEMBRANE GLYCOPROTEIN GP41 IS AN AMINO ACCEPTOR AND DONOR SUBSTRATE FOR TRANSGLUTAMINASE IN-VITRO
    MARINIELLO, L
    ESPOSITO, C
    DIPIERRO, P
    COZZOLINO, A
    PUCCI, P
    PORTA, R
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 215 (01): : 99 - 104
  • [46] Detection of IgA-binding sites on human immunodeficiency virus type-1 envelope glycoproteins, Gp120 and Gp41
    Matsuda, S
    Noda, M
    [J]. MICROBIOLOGY AND IMMUNOLOGY, 2000, 44 (11) : 923 - 929
  • [47] IDENTIFICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GLYCOPROTEIN-GP120/GP41 INTERACTING SITES BY THE IDIOTYPIC MIMICRY OF 2 MONOCLONAL-ANTIBODIES
    LOPALCO, L
    LONGHI, R
    CICCOMASCOLO, F
    DEROSSI, A
    PELAGI, M
    ANDRONICO, F
    MOORE, JP
    SCHULZ, T
    BERETTA, A
    SICCARDI, AG
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (01) : 33 - 39
  • [48] Stabilization of human immunodeficiency virus type 1 envelope glycoprotein trimers by disulfide bonds introduced into the gp41 glycoprotein ectodomain
    Farzan, M
    Choe, H
    Desjardins, E
    Sun, Y
    Kuhn, J
    Cao, J
    Archambault, D
    Kolchinsky, P
    Koch, M
    Wyatt, R
    Sodroski, J
    [J]. JOURNAL OF VIROLOGY, 1998, 72 (09) : 7620 - 7625
  • [49] ROLE OF CONSERVED GP41 CYSTEINE RESIDUES IN THE PROCESSING OF HUMAN-IMMUNODEFICIENCY-VIRUS ENVELOPE PRECURSOR AND VIRAL INFECTIVITY
    SYU, WJ
    LEE, WR
    DU, B
    YU, QC
    ESSEX, M
    LEE, TH
    [J]. JOURNAL OF VIROLOGY, 1991, 65 (11) : 6349 - 6352
  • [50] Pathogenic significance of α-N-acetylgalactosaminidase activity found in the envelope glycoprotein gp160 of human immunodeficiency virus type 1
    Yamamoto, N
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2006, 22 (03) : 262 - 271